Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-08-31Clinical Trial Update: Tandem Transplantation in Multiple Myeloma (MM) Patients With <12 Months of Prior Treatment [Phase 2]
This Phase 2 study assesses tandem autologous stem cell transplantation in multiple myeloma patients with less than 12 months of prior treat…
-
CLINICAL_TRIALS trial_result · 2017-08-30Clinical Trial Update: Cabozantinib (XL184) in Patients With Relapsed or Refractory Myeloma [Phase 1, Phase 2]
Clinical trial update on cabozantinib (XL184) in relapsed or refractory multiple myeloma reporting Phase 1/2 results; results were posted in…
-
CLINICAL_TRIALS trial_result · 2017-08-29Clinical Trial Update: Tolerability and Efficacy of Modified VCD Regimens in Previously Untreated Multiple Myeloma. [Phase 2]
This Phase 2 clinical trial update assesses tolerability and efficacy of modified VCD regimens in patients with previously untreated multipl…
-
CLINICAL_TRIALS withdrawal · 2017-08-28Clinical Trial Update: Early Patient Access Single Named Patient Program for the Use of Ulocuplumab for the Treatment of Multiple Myeloma
An early-access named-patient program using Ulocuplumab for relapsed multiple myeloma is no longer available.
-
CLINICAL_TRIALS trial_result · 2017-08-24Clinical Trial Update: Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating chemotherapy followed by unrelated donor stem cell transplantation for blood and immune system cancers; …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2017-08-24Clinical Trial Update: Pembrolizumab Cyclophosphamide and Lenalidomide for Patients With Relapsed Multiple Myeloma [Phase 1, Phase 2]
A Phase 1/2 trial evaluating pembrolizumab with cyclophosphamide and lenalidomide for relapsed multiple myeloma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: Elotuzumab in Autologous Stem Cell Transplantation (ASCT) and Lenalidomide Maintenance for Multiple Myeloma [Phase 1]
A Phase 1 trial evaluating elotuzumab in combination with autologous stem cell transplantation and lenalidomide maintenance in multiple myel…
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies [Phase 1, Phase 2]
Phase 1/2 study of oral LBH589 (panobinostat) in adults with advanced hematologic malignancies completed; results posted.
-
CLINICAL_TRIALS trial_result · 2017-08-11Clinical Trial Update: Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma [Phase 3]
Phase 3 trial comparing lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide in newly diagnosed multiple myelo…
-
CLINICAL_TRIALS research · 2017-08-10Clinical Trial Update: Low Dose Plerixafor Plus G-CSF in Mobilizing Stem Cells for Autologous Peripheral Blood Transplantation [Phase 2]
A Phase 2 trial is evaluating low-dose plerixafor plus G-CSF to mobilize stem cells for autologous peripheral blood transplantation in lymph…
-
CLINICAL_TRIALS trial_result · 2017-08-10Clinical Trial Update: Safety and Tolerability of HSC835 in Patients With Hematological Malignancies Undergoing Single Umbilical Cord Blood Transplant [Phase 2]
Phase 2 clinical trial update assessing safety and tolerability of HSC835 in patients with hematological malignancies undergoing single umbi…
-
CLINICAL_TRIALS trial_result · 2017-08-09Clinical Trial Update: A Study of Weekly Carfilzomib in Combination With Dexamethasone for Progressive Multiple Myeloma [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating weekly carfilzomib in combination with dexamethasone for progressive multiple myeloma; results were p…
-
CLINICAL_TRIALS trial_result · 2017-08-01Clinical Trial Update: Clinical And Economic Impact Of Upfront Plerixafor In Autologous Transplantation [Phase 2]
Phase 2 clinical trial update evaluating upfront plerixafor in autologous transplantation and its clinical and economic impact in Non-Hodgki…
-
CLINICAL_TRIALS trial_result · 2017-08-01Clinical Trial Update: Phase 3 Study of Carfilzomib, Melphalan, Prednisone vs Bortezomib, Melphalan, Prednisone in Newly Diagnosed Multiple Myeloma [Phase 3]
Phase 3 trial comparing carfilzomib-based induction (carfilzomib, melphalan, prednisone) versus bortezomib-based induction (bortezomib, melp…
-
CLINICAL_TRIALS trial_result · 2017-07-31Clinical Trial Update: Collection of Transplant Stem Cells for Plasma Cell Myeloma [Phase 2]
Phase 2 clinical trial update on collection of transplant stem cells for multiple myeloma, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-07-31Clinical Trial Update: Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma [Phase 1]
Phase 1 trial evaluating bendamustine in combination with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma has comp…
-
CLINICAL_TRIALS trial_result · 2017-07-26Clinical Trial Update: A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms
Completed clinical trial evaluating whether the final Geriatric Assessment in Haematology (GAH) score can predict tolerance to treatment in …
-
CLINICAL_TRIALS trial_result · 2017-07-19Clinical Trial Update: Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer [Phase 1]
A Phase 1 trial of fenretinide in patients with refractory or relapsed hematologic cancers has been completed, investigating safety across m…
-
CLINICAL_TRIALS trial_result · 2017-07-18Clinical Trial Update: Phase II Study of Velcade, Decadron, and Doxil Followed by Cyclophosphamide in Multiple Myeloma [Phase 2]
Phase II results are reported for a regimen of Velcade (bortezomib) with Decadron (dexamethasone) and Doxil (liposomal doxorubicin), followe…
-
CLINICAL_TRIALS trial_result · 2017-07-18Clinical Trial Update: Non-inferiority Study of XM02 Filgrastim (Granix) and Filgrastim (Neupogen) in Combination With Plerixafor for Autologous Stem Cell Mobilization in Patients With Multiple Myeloma or Non-Hodgkin Lymphoma [Phase 2]
A Phase 2 non-inferiority trial comparing XM02 (Granix) and filgrastim (Neupogen) when used with plerixafor for autologous stem cell mobiliz…
-
CLINICAL_TRIALS trial_result · 2017-07-17Clinical Trial Update: Preservation of Ovarian Function After Hematopoietic Cell Transplant [Phase 2]
Phase 2 trial investigating preservation of ovarian function after hematopoietic cell transplantation in patients with hematologic cancers; …
-
CLINICAL_TRIALS trial_result · 2017-07-17Clinical Trial Update: Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen [Phase 1, Phase 2]
A Phase 1/2 trial evaluating allogeneic hematopoietic cell transplantation using a busulfan-based conditioning regimen across multiple hemat…
-
CLINICAL_TRIALS research · 2017-07-13Clinical Trial Update: Study of Risk Factors and Genetic Association With Bortezomib-induced Peripheral Neuropathy in Multiple Myeloma
This clinical trial update examines risk factors and genetic associations for peripheral neuropathy caused by bortezomib in people with mult…
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: Post Transplant Donor Lymphocyte Infusion [Phase 2]
Phase 2 clinical trial update for post-transplant donor lymphocyte infusion; the study is terminated with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-07-07Clinical Trial Update: Hemostatic Effects of VELCADE®* Treatment in Multiple Myeloma Patients [Phase 2]
Phase 2 trial update evaluating hemostatic effects of VELCADE treatment in patients with multiple myeloma; study terminated with posted resu…